| Dr Veronica Soler, MD | |
|
1310 W 22nd St, Sioux Falls, SD 57105-1501 | |
| (605) 782-2000 | |
| (605) 782-2721 |
| Full Name | Dr Veronica Soler |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 1310 W 22nd St, Sioux Falls, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497749675 | NPI | - | NPPES |
| 0501916 | Medicaid | NE | |
| 6003440 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 3710 (South Dakota) | Primary |
| Entity Name | Access Telecare Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013303080 PECOS PAC ID: 7810204831 Enrollment ID: O20211201001613 |
News Archive
A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.
We know that germs can make you sick, but if you seem to constantly be under the weather with cold symptoms, could it be something other than germs that are getting you down?
Women who donate their eggs for stem cell research or in vitro fertilization are not at increased risk of health complications, and most of the risks are a result of the hormones used to stimulate their bodies to release more than one egg, according to a report commissioned by the California Institute of Regenerative Medicine and released by the Institute of Medicine, Bloomberg reports.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Veronica Soler, MD 1310 W 22nd St, Sioux Falls, SD 57105-1501 Ph: (605) 782-2000 | Dr Veronica Soler, MD 1310 W 22nd St, Sioux Falls, SD 57105-1501 Ph: (605) 782-2000 |
News Archive
A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.
Bristol-Myers Squibb Company and Pfizer report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in patients with atrial fibrillation expected to be or demonstrated to be unsuitable for warfarin therapy will be presented at the European Society of Cardiology Congress 2010. The results will be presented during the "Hot Line" session on August 31, 2010, in Stockholm, Sweden.
We know that germs can make you sick, but if you seem to constantly be under the weather with cold symptoms, could it be something other than germs that are getting you down?
Women who donate their eggs for stem cell research or in vitro fertilization are not at increased risk of health complications, and most of the risks are a result of the hormones used to stimulate their bodies to release more than one egg, according to a report commissioned by the California Institute of Regenerative Medicine and released by the Institute of Medicine, Bloomberg reports.
› Verified 1 days ago
Jaroslaw Mateuszczyk, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1205 S Grange Ave Ste 201, Sioux Falls, SD 57105 Phone: 605-328-8188 | |
Aaron Burkhardt, DO Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6100 S Louise Ave Ste 1120, Sioux Falls, SD 57108 Phone: 605-504-1700 | |
Curtis Blake Rexroth, Infectious Disease Medicare: Medicare Enrolled Practice Location: 1325 S Cliff Ave, Sioux Falls, SD 57105 Phone: 605-322-8000 | |
Vinod Parameswaran, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 E. 23rd St., Ste. 200, Sioux Falls, SD 57105 Phone: 605-322-3035 Fax: 605-322-3036 | |
Lloyd E Solberg, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1301 W 18th St, Sioux Falls, SD 57105 Phone: 605-312-2200 | |
Ismail Omran, Infectious Disease Medicare: Medicare Enrolled Practice Location: 1205 S Grange Ave Ste 201, Sioux Falls, SD 57105 Phone: 605-238-8100 | |
Francine Vanessa Arneson, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 911 E. 20th St., Ste. 509, Sioux Falls, SD 57105 Phone: 605-322-8993 |